Rakovina Therapeutics Inc (TSE:RKV) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Rakovina Therapeutics Inc. has announced a private placement offering, securing over $800,000 in initial commitments to advance their innovative cancer therapies. The funds will support the development of novel treatments using AI platforms, aiming for breakthroughs in DNA-damage response technologies.
For further insights into TSE:RKV stock, check out TipRanks’ Stock Analysis page.
